Inogen Inc (INGN) Stock Price

INGNStock

$5.50−30.90%52W

Market Cap$145.96M

P/E—

PEG Ratio—

Div yield—

Beta1.51

INGN Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-17.75%

Price vs S&P 500 (4W)-19.57%

VGM Score49.36

P/CF (Annual)29.56x

Book Value / Share (Quarterly)$6.68

P/TBV (Annual)1.13x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-2.59%

Cash Flow / Share (Quarterly)$-0.37

Price vs S&P 500 (YTD)-30.98%

Gross Margin (TTM)44.31%

Net Profit Margin (TTM)-7.08%

EPS (TTM)$-0.92

10-Day Avg Trading Volume0.22M

EPS Excl Extra (TTM)$-0.92

Revenue Growth (5Y)2.48%

EPS (Annual)$-0.86

ROI (Annual)-11.83%

Gross Margin (Annual)44.24%

Net Profit Margin (5Y Avg)-14.73%

Cash / Share (Quarterly)$4.03

Revenue Growth QoQ (YoY)3.44%

ROA (Last FY)-7.62%

Revenue Growth TTM (YoY)3.39%

EBITD / Share (TTM)$-0.42

ROE (5Y Avg)-22.47%

Operating Margin (TTM)-9.07%

Cash Flow / Share (Annual)$-0.79

P/B Ratio0.84x

P/B Ratio (Quarterly)0.92x

Net Income / Employee (Annual)$-30,200

EV / Revenue (TTM)0.17x

Net Interest Coverage (TTM)26.25x

ROA (TTM)-8.27%

EV / EBITDA (TTM)10.01x

EPS Incl Extra (Annual)$-0.86

Current Ratio (Annual)3.12x

Quick Ratio (Quarterly)2.50x

3-Month Avg Trading Volume0.29M

52-Week Price Return-30.90%

Revenue / Employee (TTM)$466,800

Tangible BV / Share (Quarterly)$5.63

P/S Ratio (Annual)0.44x

Asset Turnover (Annual)1.17x

52-Week High$9.13

Operating Margin (5Y Avg)-15.20%

EPS Excl Extra (Annual)$-0.86

CapEx CAGR (5Y)-10.02%

Tangible BV CAGR (5Y)-10.48%

26-Week Price Return-5.82%

Quick Ratio (Annual)2.51x

13-Week Price Return-15.90%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)3.10x

Enterprise Value$61.08M

Revenue / Share Growth (5Y)-1.34%

Asset Turnover (TTM)1.17x

Book Value / Share Growth (5Y)-14.91%

Revenue / Employee (Annual)$463,000

Inventory Turnover (Annual)7.66x

Pretax Margin (Annual)-6.71%

Cash / Share (Annual)$4.39

3-Month Return Std Dev41.21%

Gross Margin (5Y Avg)44.09%

Net Income / Employee (TTM)$-33,100

ROE (Last FY)-11.83%

Net Interest Coverage (Annual)13.86x

EPS Basic Excl Extra (Annual)$-0.86

P/FCF (TTM)283.43x

Receivables Turnover (TTM)8.96x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.92

Receivables Turnover (Annual)10.19x

ROI (TTM)-12.90%

P/S Ratio (TTM)0.44x

Pretax Margin (5Y Avg)-13.93%

Revenue / Share (Annual)$13.11

Tangible BV / Share (Annual)$5.93

Price vs S&P 500 (52W)-49.46%

Year-to-Date Return-18.15%

5-Day Price Return0.00%

EPS Normalized (Annual)$-0.86

ROA (5Y Avg)-14.63%

Net Profit Margin (Annual)-6.52%

Month-to-Date Return-14.73%

Cash Flow / Share (TTM)$-5.02

EBITD / Share (Annual)$-0.95

Operating Margin (Annual)-8.66%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-22.47%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.92

P/TBV (Quarterly)1.09x

P/B Ratio (Annual)0.95x

Inventory Turnover (TTM)7.64x

Pretax Margin (TTM)-7.28%

Book Value / Share (Annual)$7.06

Price vs S&P 500 (13W)-17.86%

Beta1.51x

P/FCF (Annual)7.94x

Revenue / Share (TTM)$12.86

ROE (TTM)-12.90%

52-Week Low$5.34

vGradeB

gGradeD

mGradeC

vgmGradeC

INGN Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 6, 2026	-$0.06	$0.00	+100.00%(+$0.06)
Q1 2026	May 7, 2026	-$0.21	-$0.14	+33.33%(+$0.07)
Q4 2025	Feb 24, 2026	-$0.18	-$0.15	+16.67%(+$0.03)
Q3 2025	Nov 5, 2025	-$0.09	-$0.02	+77.78%(+$0.07)
Q2 2025	Aug 7, 2025	-$0.09	-$0.02	+77.78%(+$0.07)

INGN Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.11

Industry Peers — Orthopedic & Prosthetic Devices(33)

Symbol	Value Score	Growth Score	Momentum Score	Price
INGNInogen Inc	B	D	C	$5.50
ISRGIntuitive Surgical Inc.	D	B	C	$372.60
EWEdwards Lifesciences Corp	D	C	B	$90.21
STESTERIS plc	C	B	C	$233.78
ZBHZimmer Biomet Holdings, Inc.	B	C	B	$100.91
SNNSmith & Nephew plc	B	C	C	$28.97
ALGNAlign Technology Inc	B	D	C	$157.58
MSAMine Safety Incorporated	C	C	B	$190.34
ESTAEstablishment Labs Holdings Inc.	F	A	C	$70.64
ENOVEnovis Corporation	B	D	C	$24.90
CDRECadre Holdings, Inc.	C	C	C	$30.74
AVNSAvanos Medical, Inc.	B	D	C	$24.99
AVRAnteris Technologies Global Corp. Common Stock	F	D	B	$8.74
SMTISanara MedTech Inc. Common Stock	D	C	B	$34.57
CNXUConexeu Sciences Inc. Common Stock	—	—	F	$7.07
ZJYLJIN MEDICAL INTERNATIONAL LTD. Class A Ordinary Shares	B	D	D	$2.34
LAKELakeland Industries Inc	B	D	B	$11.86
SPAISafe Pro Group Inc. Common Stock	F	C	D	$4.63
MYOMyomo Inc.	C	B	A	$1.60
APTAlpha Pro Tech, Ltd.	A	D	C	$5.35
NTRBNutriband Inc. Common Stock	F	D	C	$4.46
COCHEnvoy Medical, Inc. Class A Common Stock	D	D	D	$0.69
MLSSMilestone Scientific, Inc. Common Stock	D	D	B	$0.50
LFWDLifeward Ltd. Ordinary Shares	B	D	B	$7.46
RGNTRegentis Biomaterials Ltd.	—	—	D	$2.00
HSCSHeartSciences Inc. Common Stock	F	F	B	$3.03
CUPRCuprina Holdings (Cayman) Limited Class A Ordinary Shares	—	D	C	$3.01
CLGNCollPlant Biotechnologies Ltd Ordinary Shares	C	F	D	$0.36
FEEDENvue Medical, Inc. Common Stock	A	F	F	$0.34
BBLGBone Biologics Corp Common Stock	—	—	D	$0.61
BBLGWBone Biologics Corp Warrants	—	—	F	$5.70
COCHWEnvoy Medical, Inc Warrant	—	—	C	$0.04
HSCSWHeartSciences Inc. Warrant	—	—	D	$0.04
NTRBWNutriband Inc. Warrant	—	—	D	$0.45

About Inogen Inc

Inogen Inc develops and manufactures respiratory care products for patients with chronic respiratory conditions, including portable and stationary oxygen concentrators, airway clearance devices, and CPAP masks. The company generates revenue through product sales and equipment rental services across its respiratory health solutions portfolio.